Real-time enrollment status for this head and neck squamous cell carcinoma (hnscc) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 7:34 PM UTC
| NCT Number | NCT06769698 |
| Recruiting Status | Recruiting |
| Condition | Head and Neck Squamous Cell Carcinoma (HNSCC) |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | August 21, 2026 (6 days ago) |
As of August 27, 2026: Clinical trial NCT06769698 is currently recruiting participants. This phase2 study for head and neck squamous cell carcinoma (hnscc) is actively seeking new participants at 18 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06769698 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06769698 was last updated 6 days ago (August 21, 2026). HelloStudys verifies this status automatically.